Publicaciones en las que colabora con Mariano Barbacid Montalbán (33)

2017

  1. H-Ras and K-Ras oncoproteins induce different tumor spectra when driven by the same regulatory sequences

    Cancer Research, Vol. 77, Núm. 3, pp. 707-718

2014

  1. K-RasV14I recapitulates noonan syndrome in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 46, pp. 16395-16400

2013

  1. Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: Functional and mechanistic implications

    BMC Genomics, Vol. 14, Núm. 1

2011

  1. Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 12, pp. 5015-5020

2010

  1. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival

    EMBO Journal, Vol. 29, Núm. 6, pp. 1091-1104

2008

  1. A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition

    Journal of Clinical Investigation, Vol. 118, Núm. 6, pp. 2169-2179

1997

  1. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation

    Oncogene, Vol. 15, Núm. 21, pp. 2511-2520

1996

  1. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes

    Oncogene, Vol. 13, Núm. 2, pp. 363-371

  2. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav

    Oncogene, Vol. 13, Núm. 3, pp. 455-460

  3. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor

    Oncogene, Vol. 12, Núm. 3, pp. 463-470

1995

  1. Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins

    Molecular and Cellular Biology, Vol. 15, Núm. 3, pp. 1324-1332

  2. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation

    Oncogene, Vol. 10, Núm. 10, pp. 1905-1913

  3. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells

    Oncogene, Vol. 11, Núm. 5, pp. 825-831

1994

  1. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav

    Molecular and Cellular Biology, Vol. 14, Núm. 4, pp. 2777-2785

  2. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor

    Oncogene, Vol. 9, Núm. 8, pp. 2405-2413

  3. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C ζ and the vav and c-raf proto-oncogene products

    Journal of Biological Chemistry, Vol. 269, Núm. 15, pp. 11590-11594

1993

  1. Developmental expression of the vav protooncogene.

    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, Vol. 4, Núm. 4, pp. 297-308

  2. Molecular cloning of the mouse grb2 gene: Differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors

    Molecular and Cellular Biology, Vol. 13, Núm. 9, pp. 5500-5512

1992

  1. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates

    Nature, Vol. 356, Núm. 6364, pp. 68-71

  2. Steel factor stimulates the tyrosine phosphorylation of the protooncogene product, p95vav, in human hemopoietic cells

    Journal of Biological Chemistry, Vol. 267, Núm. 25, pp. 18021-18025